Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Nov 12, 2009

Premium

Exiqon announced that it has named Mark Willig as its chief commercial officer.

He will be responsible for managing the company’s sales and marketing efforts for all products and services.

Willig most recently served as vice president of global sales at Thermo Fisher Scientific.


Mirna Therapeutics has appointed Paul Lammers as its president, CEO, and board member.

Lammers was most recently president of Repros Therapeutics. Before that, he was CEO of EMD Serono. He holds an MD and MSc from Catholic University in the Netherlands.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.